Compare

Vicarious Surgical Inc. vs Lifeward Ltd. vs CollPlant Biotechnologies Ltd vs Myomo, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearVicarious Surgical Inc.
RBOT
Lifeward Ltd.
LFWD
CollPlant Biotechnologies Ltd
OPHI
Myomo, Inc.
MYO
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenuen/a$22.03M$2.37M$40.93M
Revenue growth (YoY)n/a-14.1%+360.4%+25.7%
Gross marginn/a38.2%64.8%65.7%
Operating marginn/a-89.3%-484.3%-35.2%
Net marginn/a-90.4%-484.6%-38.1%
Net income-$50.18M-$19.91M-$11.49M-$15.57M
EPS (Diluted)n/a-$17.16-$0.94-$0.37
Operating cash flow-$45.08M-$16.83M-$9.42M-$14.51M
Free cash flow-$45.21M-$16.84M-$9.45M-$16.25M
Cash & equivalents$2.57M$2.17M$5.59M$14.13M
Total assets$19.58M$22.90M$10.79M$38.64M
Total liabilities$9.74M$14.49M$4.70M$27.23M
Shareholders' equity$9.84M$8.41M$6.08M$11.40M
Return on year-end equity-509.9%-236.8%-188.9%-136.6%
Shares outstandingn/a1.52M12.80M38.47M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearVicarious Surgical Inc.Lifeward Ltd.CollPlant Biotechnologies LtdMyomo, Inc.
Latestn/a$22.03M
Ended 2025-12-31
$2.37M
Ended 2025-12-31
$40.93M
Ended 2025-12-31
1 year earliern/a$25.66M
Ended 2024-12-31
$515.0K
Ended 2024-12-31
$32.55M
Ended 2024-12-31
2 years earliern/a$13.85M
Ended 2023-12-31
$10.96M
Ended 2023-12-31
$19.24M
Ended 2023-12-31
3 years earliern/a$5.51M
Ended 2022-12-31
$299.0K
Ended 2022-12-31
$15.56M
Ended 2022-12-31
4 years earliern/a$5.97M
Ended 2021-12-31
$15.64M
Ended 2021-12-31
$13.86M
Ended 2021-12-31